Literature DB >> 8294911

Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and junB in PC12 cells.

C Haby1, F Lisovoski, D Aunis, J Zwiller.   

Abstract

Stimulation of several second messenger pathways induces the expression of immediate early genes such as c-fos, c-jun, junB, and junD, but little is known about their induction via the stimulation of the cyclic GMP pathway. Here we looked at the expression of early genes in pheochromocytoma PC12 cells after activation of cytosolic guanylate cyclase by sodium nitroprusside. This compound spontaneously releases NO, a molecule known to be involved in cell communication. We found that expression of c-fos and junB but not of c-jun or junD is increased upon activation of cyclic GMP pathway. c-fos mRNA expression was the most activated (fourfold at 30 min), whereas junB response was more modest (2.2-fold activation at 60 min). Nuclear extracts of stimulated cells show increased binding capacity to the AP1 binding site consistent with the dose-response curve. The activating effect of nitroprusside could be reproduced by dipyridamole, a selective cyclic GMP phosphodiesterase inhibitor and by 8-p-chlorophenylthio-cyclic GMP, a permeant selective cyclic GMP-dependent protein kinase activator, and abolished by KT5823, an inhibitor of that kinase. The results show that NO promotes early gene activation and AP1 binding enhancement through the stimulation of the cyclic GMP pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294911     DOI: 10.1046/j.1471-4159.1994.62020496.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  28 in total

1.  Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus.

Authors:  Y F Lu; E R Kandel; R D Hawkins
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Pressor response to pulsatile compression of the rostral ventrolateral medulla mediated by nitric oxide and c-fos expression.

Authors:  S Morimoto; S Sasaki; S Miki; T Kawa; H Itoh; T Nakata; K Takeda; M Nakagawa
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal.

Authors:  T Gudi; S M Lohmann; R B Pilz
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Neuronal differentiation and protection from nitric oxide-induced apoptosis require c-Jun-dependent expression of NCAM140.

Authors:  Zhiwei Feng; Lei Li; Poh Yong Ng; Alan G Porter
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 5.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

6.  Nitric oxidergic cells related to ejaculation in gerbil forebrain contain androgen receptor and respond to testosterone.

Authors:  Danielle A Simmons; Pauline Yahr
Journal:  J Comp Neurol       Date:  2011-04-01       Impact factor: 3.215

7.  Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway.

Authors:  Valya Ramakrishnan; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2011-04-15       Impact factor: 3.039

8.  Down-regulation of iron regulatory protein 1 gene expression by nitric oxide.

Authors:  L Oliveira; J C Drapier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  The role of prostaglandins in triggering the liver regeneration cascade.

Authors:  Jodi M Schoen Smith; W Wayne Lautt
Journal:  Nitric Oxide       Date:  2005-09       Impact factor: 4.427

10.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.

Authors:  Vladan P Cokic; Reginald D Smith; Bojana B Beleslin-Cokic; Joyce M Njoroge; Jeffery L Miller; Mark T Gladwin; Alan N Schechter
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.